Robert D. King - 29 Aug 2025 Form 4 Insider Report for Corteva, Inc. (CTVA)

Role
EVP, Crop Protection Business
Signature
/s/Abigail Jarrell, by power-of-attorney
Issuer symbol
CTVA
Transactions as of
29 Aug 2025
Net transactions value
-$1,306,688
Form type
4
Filing time
02 Sep 2025, 17:20:18 UTC
Previous filing
08 Apr 2025
Next filing
29 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
King Robert D. EVP, Crop Protection Business C/O CORTEVA, INC., 9330 ZIONSVILLE ROAD, INDIANAPOLIS /s/Abigail Jarrell, by power-of-attorney 02 Sep 2025 0001921979

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTVA Common Stock Options Exercise $877,703 +14,960 +24% $58.67 77,180 29 Aug 2025 Direct
transaction CTVA Common Stock Options Exercise $581,602 +9,337 +12% $62.29 86,517 29 Aug 2025 Direct
transaction CTVA Common Stock Sale $2,765,993 -37,280 -43% $74.20 49,262 29 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTVA Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -14,960 -100% $0.000000 0 29 Aug 2025 Common Stock 14,960 $58.67 Direct F3
transaction CTVA Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -9,337 -67% $0.000000 4,669 29 Aug 2025 Common Stock 9,337 $62.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $74.17 to $74.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Includes acquisition of 25.3808 shares pursuant to dividend reinvestment.
F3 The options became fully exercisable on April 4, 2025, the third anniversary of the grant date.
F4 One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025, and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.